Labcorp Clinical Trials is a business segment of Labcorp Inc., a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Labcorp is a registered trademark and the marketing name for Labcorp Inc. and its subsidiaries around the world.
1 Stay of 5 nights & 2 Calls
8501-085 3b Cohort 3b
Back To Current Studies1 Stay of 5 nights & 2 Calls
Study Number
8501-085 3bGroup
Cohort 3bGender
bothAge
18 - 45Location
Daytona Beach, FloridaCompensation
$3,830Study Dates
Feb. 05 - Mar. 10, 2023Additional Information
The purpose of Cohort 3 is to evaluate the effects of the study drug on the amount of dabigatran etexilate that reaches the blood stream and how long the body takes to get rid of it. Dabigatran etexilate is a blood thinning drug that can increase the risk of bleeding because it lessens the ability of the blood to clot. The safety and tolerability of the study drug when given alone and when given with dabigatran etexilate will be evaluated and information about any side effects that may occur will be collected.
Labcorp Daytona Beach, FL is recruiting for:
- Healthy Adults, age 18-45
- Body Mass Index between 18-30
- Study involves 1 stay of 5 nights, plus 2 Phone Calls
- Compensation up to $3,830 may be provided for time and participation
- Receive up to $200 per qualified referral
Details
Call Now to Schedule Your Screening Appointment!
Cohort 3b:
Check-in: Feb 5
Check-out: Feb 10
Phone Calls: Feb 15 & Mar 10
Calculate Your BMI!
Your Height:
ft / in
Your Weight:
lbs
Select Measurement System:
Your BMI:
result